Immucell Cp (ICCC) 6.75 $ICCC ImmuCell Announces First

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 2:12 PM

Immucell Cp (ICCC) 6.75 $ICCC

ImmuCell Announces First Quarter 2016 Financial Results
Marketwired - Wed May 11, 3:16PM CDT
PORTLAND, ME--(Marketwired - May 11, 2016) - ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its first quarter ended March 31, 2016.
ICCC: 6.75 (+0.28)

ImmuCell to Announce First Quarter 2016 Financial Results
Marketwired - Wed May 04, 12:15PM CDT
Conference Call Scheduled for Wednesday, May 11, 2016 at 4:30 PM EST
ICCC: 6.75 (+0.28)

ImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations
Marketwired - Mon Apr 04, 4:41PM CDT
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the hiring of Ms. Elizabeth L. Williams as Vice President of Manufacturing Operations.
ICCC: 6.75 (+0.28)

ImmuCell Announces Full Year 2015 Financial Results
Marketwired - Wed Feb 10, 3:05PM CST
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its fourth quarter and year ended December 31, 2015.
ICCC: 6.75 (+0.28)

ImmuCell to Announce 2015 Financial Results
Marketwired - Thu Feb 04, 7:01AM CST
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, will report financial results for the fourth quarter and year ended December 31, 2015 after the market closes on Wednesday, February 10, 2016. The Company has scheduled a conference call that same day Wednesday, February 10, 2016 at 4:30 PM ET to review the results.
ICCC: 6.75 (+0.28)

ImmuCell raises USD5.9m from public offering
M2 - Thu Feb 04, 3:00AM CST
Animal health company ImmuCell (NasdaqCM:ICCC) reported on Wednesday the completion of its public offering of 1,123,810 common stock at a price of USD5.25 per share.
ICCC: 6.75 (+0.28)

ImmuCell Corporation Announces Closing of $5.9 Million Public Offering of Common Stock
Marketwired - Wed Feb 03, 9:45AM CST
ImmuCell Corporation ("ImmuCell" or the "Company"

(NASDAQ: ICCC), an animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the closing of a previously announced underwritten public offering of 1,123,810 shares of common stock at a price to the public of $5.25 per share (the "Offering"

.
ICCC: 6.75 (+0.28)

BUYINS.NET: NVAX, DST, MSL, ICCC, HBAN, UBNK, Expected to Trade Higher After Bullish Insider Trading
M2 - Tue Feb 02, 9:04AM CST
BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Higher in the next 6 months. Novavax Inc (NASDAQ:NVAX), DST Systems Inc (NYSE

ST), MidSouth Bancorp Inc (NYSE:MSL), ImmuCell Corp (NASDAQ:ICCC), HUNTINGTON BANCSHARES INCORPORATED (NASDAQ:HBAN), United Financial Bancorp Inc (NASDAQ:UBNK) are all expected to go Higher as Buy signals have been generated by top insider trading patterns.
HBAN: 8.72 (+0.14), MSL: 10.10 (+0.05), NVAX: 7.62 (+0.16), ICCC: 6.75 (+0.28), UBNK: 13.20 (+0.41), DST: 119.52 (+2.88)

ImmuCell prices USD5.9m in public offering
M2 - Mon Feb 01, 3:45AM CST
Animal health company ImmuCell (NasdaqCM:ICCC) said on Friday that it has priced its public offering of 1,123,810 shares of its common stock.
ICCC: 6.75 (+0.28)

ImmuCell Corporation Announces Pricing of $5.9 Million Public Offering of Common Shares
Marketwired - Fri Jan 29, 6:30AM CST
ImmuCell Corporation ("ImmuCell" or the "Company"

at a price to the public of $5.25 per share. Net proceeds to the Company from the Offering are expected to be approximately $5.3 million, after deducting underwriting commissions and other expenses related to the Offering.
ICCC: 6.75 (+0.28)

ImmuCell Corporation Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results
Marketwired - Thu Jan 28, 4:53PM CST
ImmuCell Corporation ("ImmuCell" or the "Company"

(NASDAQ: ICCC), an animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced a proposed registered underwritten public offering of its common stock, subject to market and other conditions.
ICCC: 6.75 (+0.28)

ImmuCell Acquires Certain Assets From Minnesota Firm
Marketwired - Wed Jan 06, 7:01AM CST
ImmuCell Corporation (NASDAQ: ICCC), a rapidly growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced that it has acquired certain business assets from DAY 1(TM) Technology, LLC of Minnesota.
ICCC: 6.75 (+0.28)

ImmuCell Enters Into New Contract With Norbrook
Marketwired - Tue Dec 22, 7:00AM CST
ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced that it has entered into a Product Development & Contract Manufacture Agreement with Norbrook Laboratories Limited of Newry, Northern Ireland (Norbrook), a global leader in the development of revolutionary veterinary and animal health medicine, covering the final formulation and sterile-filling services for Mast OutÂ®.
ICCC: 6.75 (+0.28)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

By Riley Hayes Updated Oct 24, 2026 Category News Views 239

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...